Despite constant calls to inform oneself through official sources and not to overreact to seemingly miraculous treatments, containment exacerbates the virality of information, whether true or not.
In this context, the International Association for Cannabinoids in Medicine (IACM), headed by Dr. Kirsten Müller-Vahl and Dr. Franjo Grotenhermen, made a point of recalling in its monthly newsletter that cannabis does not cure coronavirus.
Several laboratory studies suggest that cannabinoids may have antiviral and antibacterial effects. We have reported on this several times in the IACM Bulletin.
However, there is no evidence that individual cannabinoids – such as CBD, CBG or THC – or cannabis preparations protect against infection with the SARS-CoV2 virus or could be used to treat Covid-19, the disease produced by this virus.
Furthermore, there is no evidence that the use of cannabinoids could increase the risk of viral infection.